period,total_demand,total_supply,shortage_amount,unsold,shortage_percentage,disrupted_manufacturers,fda_announcement
0,1.1,0.85,0.2500000000000001,0.0,0.22727272727272735,[0],The FDA continues to monitor market conditions closely. Current supplies remain adequate with minimal disruptions reported. We encourage stakeholders to report any supply issues promptly.
1,1.3,0.85,0.45000000000000007,0.0,0.3461538461538462,[0],The FDA is aware of an emerging shortage situation involving critical drugs. We encourage healthcare providers and manufacturers to report supply issues. The FDA is monitoring the situation closely to ensure patient safety and market stability.
2,1.2,1.075,0.125,0.07499999999999996,0.10416666666666667,[0],The FDA is actively monitoring an emerging drug shortage and is aware of manufacturing disruptions. We encourage manufacturers to report any additional production challenges to facilitate timely interventions.
3,1.2,1.075,0.125,0.07499999999999996,0.10416666666666667,[0],The FDA is aware of an emerging supply issue for [drug name] due to a disruption with one manufacturer. We are actively monitoring the situation and encourage stakeholders to report any significant changes in supply conditions.
